慢性心力衰竭和抑郁症治疗选择的比较分析:系统性审查和贝叶斯网络元分析
Hamidreza Soleimani1,2,3, Ali Nasrollahizadeh1,4, Mohsen Hajiqasemi1,5
1Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Heart failure reviews
|April 13, 2024
概括
认知行为疗法 (CBT) 是减少心力衰竭患者抑郁症的最有效治疗方法. 这次元分析发现,CBT与常规护理相比,显著改善了抑郁症得分,为这个患者群体提供了明确的建议.
科学领域:
- 心脏病学 心脏病学
- 精神病学是一个精神病学.
- 基于证据的医学基于证据的医学.
背景情况:
- 抑郁症是心力衰竭 (HF) 患者常见的并发症.
- 目前尚缺少针对HF抑郁症的有效治疗建议.
- 这突显了心血管疾病的并发症状况管理中的关键差距.
研究的目的:
- 系统地评估和比较治疗心力衰竭患者抑郁症的各种干预措施的疗效.
- 根据可用的随机对照试验 (RCT) 证据,确定最有效的治疗策略.
- 为临床实践提供基于证据的建议.
主要方法:
- 在PubMed,Scopus和Web of Science数据库中进行了系统的文献搜索.
- 包括随机对照试验 (RCT),评估治疗对HF患者抑郁症得分的影响.
- 进行了贝叶斯网络元分析,主要结果是抑郁症得分变化 (标准化平均差异 - SMD).
主要成果:
- 分析了25个涉及6014名患者的RCT.
- 认知行为疗法 (CBT) 与通常治疗 (TAU) 相比,显著降低了抑郁症得分 (SMD: -0.60,95% CI: [-1.0, -0.17).
- 其他评估的干预措施都没有显示出抑郁症得分的统计学上显著改善.
结论:
- 认知行为疗法 (CBT) 是唯一一种干预方法,可以显著缓解心力衰竭患者的抑郁症状.
- 认知性心理治疗 (CBT) 已成为HF患者共患抑郁症最有效的治疗方案.
- 这些发现支持将CBT纳入心力衰竭管理的标准护理方案.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:22Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
01:23Antidepressant Drugs: MAOIs and Other Agents
227
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
01:26Heart Failure Drugs: Inotropic Agents
577
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
577
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:18Depression: Overview
242
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
242